Related Experiment Video
Updated: Mar 8, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination
Andrew Kwong1, Martina Sanlorenzo2, Klemens Rappersberger3
1Keck School of Medicine of USC (University of Southern California), Los Angeles, CA, USA.
Abstract:
Early stage melanomas can achieve remarkable outcomes with surgery alone, but stage IV metastatic melanoma requires significant intervention and has poor outcomes. Here we present evidence on the latest advances in melanoma treatment, discuss the scientific concepts behind new therapies, and analyze the potential of future treatment combinations.
Insights
Metastatic melanoma (stage IV) has poor outcomes, unlike early-stage disease. This review covers recent melanoma treatment advances, underlying science, and future combination therapy potential.
Area of Science:
- Oncology
- Dermatology
- Cancer Research
Background:
- Early-stage melanoma is surgically curable.
- Stage IV metastatic melanoma presents significant therapeutic challenges with poor prognoses.
Purpose of the Study:
- To review the latest advances in melanoma treatment.
- To discuss the scientific principles of novel melanoma therapies.
- To analyze the potential of future combination treatments for melanoma.
Main Methods:
- Literature review of recent melanoma research.
- Analysis of scientific data on emerging therapies.
- Evaluation of potential treatment strategies.
Main Results:
- Significant progress has been made in melanoma treatment modalities.
- Novel therapies are based on a deeper understanding of melanoma biology.
- Combination therapies show promise for improved patient outcomes.
Conclusions:
- Advances in melanoma treatment offer new hope for patients.
- Understanding the science behind therapies is crucial for development.
- Future research should focus on optimizing combination treatment approaches for metastatic melanoma.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

